Back to News
AI
Zealand Pharma taps Generate’s AI in obesity deal worth up to $1.2 billion
Crypto Briefing·October 13, 2026·1 min read
AI Summary
Zealand Pharma has partnered with Generate's AI platform in a collaboration valued at up to $1.2 billion to develop obesity treatments. The deal focuses on using AI to design multispecific proteins that could offer new therapeutic strategies for treating complex metabolic conditions.
From the source
Zealand's AI-driven obesity drug collaboration could redefine treatment strategies, emphasizing multispecific proteins for complex conditions. The post Zealand Pharma taps Generate’s AI in obesity deal worth up to $1.2 billion appeared first on Crypto Briefin…
The full text couldn't be loaded here (the source may require a subscription).
View original at Crypto BriefingKeep reading
Humanoid Robots with Physical AI Deployed at Construction Sites to Address Labor Shortages and Aging Workforce in Japannews.yahoo.co.jp · 2h agoFinancing AI infrastructure with Chinese elements requires a new playbook - Pinsent Masonspinsentmasons.com · 2h agoHow Do Open-Weight AI Models Work?estadao.com.br · 2h agoWall Street muscles higher despite more swings for AI stocks - CommBankcommbank.com.au · 3h ago
Was this useful?